Is arterial ductal stent as effective as surgical shunt for palliation in staged repair of tetralogy of Fallot with pulmonary stenosis?
Interdisciplinary CardioVascular and Thoracic Surgery · 2025
DOI: 10.1093/icvts/ivaf088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2025. Verfasst von Yan Le Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, National Heart Institute, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Tetralogy of Fallot, Stents, Palliative Care, Pulmonary Valve Stenosis. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION A staged repair strategy in the form of Modified Blalock-Taussig-Thomas shunt has been performed to facilitate the growth of pulmonary valve annulus, so that patients with marginally small annulus could benefit from pulmonary valve-sparing repair. However, little has been reported on the influence of arterial ductal stent (ADS) on the growth of pulmonary annulus and pulmonary artery, with subsequent valve-sparing repair. METHODS Patients who underwent staged repair of tetralogy of Fallot with Pulmonary Stenosis with either ADS or surgical shunt were included. Echocardiographic and angiographic measurements of pulmonary annulus and pulmonary artery prior to initial palliation and complete repair were recorded. RESULTS A total of 110 patients were included, 44 (40%) patients underwent ADS and 66 (60%) patients had surgical shunt. Pulmonary annulus and pulmonary arteries grew significantly following palliation with both ADS (P = 0.011) and surgical shunt (P < 0.01), with a similar rate of increment (P = 0.205). There was no significant difference in the rate of valve-sparing repair between the 2 groups (MBTTS, 62.1% vs ADS, 47.7%, P = 0.149). However, patients who underwent ADS had shorter stays in hospital (P = 0.048). Reintervention rate and mortality rate in the interstage period were similar in both groups (P = 0.229 and P = 0.210, respectively). There was no reintervention in patients who successfully underwent valve-sparing repair following both palliation groups in the follow-up period. CONCLUSIONS ADS is as effective as surgical shunt as a palliative procedure in promoting the growth of pulmonary annulus and pulmonary arteries, with comparable rate of valve-sparing repair during corrective surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic and Vascular Surgery, National Heart Institute, Kuala Lumpur, Malaysia.
- Department of Paediatric Cardiac Surgery, UN Mehta Institute of Cardiology and Research, Ahmedabad, India.
- Paediatric and Congenital Heart Centre, National Heart Institute, Kuala Lumpur, Malaysia.
- Clinical Research Department, National Heart Institute, Kuala Lumpur, Malaysia.
ORCID-Profile: Yan Le Ho, Sivakumar Sivalingam
Zitieren
APA
Ho, Y. L., Haranal, M., Che Mood, M., Ajik, E. M., Basran, N. F., Alwi, M., & Sivalingam, S. (2025). Is arterial ductal stent as effective as surgical shunt for palliation in staged repair of tetralogy of Fallot with pulmonary stenosis?. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf088
Vancouver
Ho YL, Haranal M, Che Mood M, Ajik EM, Basran NF, Alwi M, et al. Is arterial ductal stent as effective as surgical shunt for palliation in staged repair of tetralogy of Fallot with pulmonary stenosis?. Interdisciplinary CardioVascular and Thoracic Surgery. 2025. doi:10.1093/icvts/ivaf088
BibTeX
@article{Ho2025,
author = {Ho, Yan Le and Haranal, Maruti and Che Mood, Marhisham and Ajik, Esther Mathias and Basran, Nurul Fazira and Alwi, Mazeni and Sivalingam, Sivakumar},
title = {Is arterial ductal stent as effective as surgical shunt for palliation in staged repair of tetralogy of Fallot with pulmonary stenosis?},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2025},
doi = {10.1093/icvts/ivaf088}
}
EUVIMED